# Studies of Elevated Parathyroid Activity

> **NCT00001277** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 1553 (actual)

## Conditions studied

- Hyperparathyroidism
- Hypercalcemia
- Parathyroid Neoplasm
- Multiple Endocrine Neoplasia
- MEN1

## Interventions

- **DRUG:** 68Ga-Dotatate
- **DRUG:** 18F-DOPA

## Key facts

- **NCT ID:** NCT00001277
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-12-15
- **Primary completion:** 2020-03-11
- **Final completion:** 2020-12-23
- **Target enrollment:** 1553 (ACTUAL)
- **Last updated:** 2022-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001277, "Studies of Elevated Parathyroid Activity". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00001277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*